Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Ser473 appears to be phosphorylated mainly by the rapamycin-insensitive mTOR complex mTORC2 (80).”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 7×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“The tyrosine residues phosphorylated in each substrate occur in specific sequence motifs; once phosphorylated, they serve as docking sites for intracellular molecules containing SH2 (Src homology 2) domains (1).”
BackgroundSelf-citationInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · cited 1×
“In part, variability may reflect the presence of three Akt isoforms (88).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“Hirosumi J, et al. A central role for JNK in obesity and insulin resistance.”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“PI-(3,4,5)P3 recruits the serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) to the plasma membrane through its PH domain and phosphorylates Thr308 on Akt (78, 79).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 5×
“Other AGC kinases activated downstream of PI3K include the protein kinase C (PKC) family, particularly PKC-ζ.”
BackgroundInfluential
Research works printed but not linked: 4
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
- 10.1172/JCI23096 · doi:10.1172/jci23096 · Paper page
- 10.1210/jcem.82.6.3979 · doi:10.1210/jcem.82.6.3979 · Paper page
Cited by
Items 401–448 of 448
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751143
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751134
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751131
VDAC1: at the crossroads of cancer signalling and metabolism
Choudhari, M., Taunk, K., Kalita, B., & Rapole, S. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2607512 · Cited by 2
Glia Regulate the Timing of Photoreceptor Differentiation in the Drosophila Visual System
Ren, Q., Chang, W.-T., & Rao, Y. (2025) · Glia · doi:10.1002/glia.70133
Mihalache, L., & Graur, L. I. (2025) · Springer eBooks · doi:10.1007/978-3-032-11445-7_8 · Cited by 1
Jawamis, A., Al-Domi, H. A., & Sarayreh, N. A. (2026) · Nutrition · doi:10.1016/j.nut.2026.113119
ZEMB, P. A., & Joulia, F. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6068352
Pathogens Aggravating Insulin Resistance
Anshi, Sharma, S., Deepika, Yadav, A. K., & Sharma, V. (2026) · Wiley eBooks · doi:10.1002/9781394293148.ch12
Zhao, Q., Tian, C., Zhao, J., Chen, G., Wang, Q. D., Yang, J., Ruan, G., & Zhao, X. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02059-0
Nazari, A., Cheraghi, M., & Souri, F. (2025) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26451
Pontes, R. D. F. C., Romão, J. S., da Silva, N. P. D. F., Joppert, M. F., Pontes, A. C. C. C., Souza, L. C. S. E., de Andrade, C. B. V., Aiceles, V., Ribas, J. A. S., & Oliveira, K. J. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112793
Zhang, L., Zhang, M., Zhu, M., Luo, X., Cui, L., Zhao, Y., & Zhao, J.-M. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112801
Zhang, Q., Zhang, Z., Wang, S., Liu, Y., Lin, L., Peng, J., & Liu, A. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02184-8
Weng, X., Huang, M., & Wang, W. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112809
Welch, H. C. E. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112566
Mo, X., Duan, Z., Zhang, W., & Jia, Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1791522 · Cited by 1
“…to phosphatidylinositol (3,4,5)-trisphosphate (PIP3), and the generation of PIP3 is a key signaling step, which activates the downstream Akt protein kinase via phosphatidylinositol-dependent kinase 1 (PDPK1) to initiate a series of metabolic and physiological processes in the cell (Saltiel, 2021).”
A computational analysis of multi-target mechanisms linking bisphenol A to precocious puberty
Zhang, J., Zhu, J., Wu, Y., Zhou, H., & Zhang, Z. (2026) · PeerJ · doi:10.7717/peerj.21261
“This interpretation is biologically plausible because insulin and IGF signaling play key roles in somatic growth, energy homeostasis, and reproductive neuroendocrine regulation ( Wolfe, Divall & Wu, 2014 ; Saltiel, 2021 ; Shi, Jiang & Zhang, 2022 ).”
Krishnan, M., & Babu, S. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70500
Lee, C. Y. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03577-8
Zheng, M., Wang, C., Liu, J., Xia, Y., Zhang, X., & Gu, L. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61190-9
Li, J., Wenjing, H., Li, C., Kuang, H., & Wang, M. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105889
Chen, X., Ma, K., Shi, Y., Li, Y., Ji, Y., & Liu, Y. (2026) · Microorganisms · doi:10.3390/microorganisms14061356
“Impaired insulin-receptor binding and signal transduction are established mechanisms underlying IR [26].”
Genome-wide variation landscape reveals temperature adaptation in Chinese indigenous cattle
Zhao, C., Teng, J., Chen, Y., Yang, C., Zhang, X., Ning, C., Wang, H., Yang, Q., Lv, W., Wang, D., et al. (2026) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-026-01451-6
Li, S., Wu, M., Zhang, M., Zihang, X., Lai, J., Zhan, L., Deng, Z., Cai, G., Gong, J., Han, C., et al. (2026) · Marine Biotechnology · doi:10.1007/s10126-026-10662-x
GULP1 enhances GLUT4 translocation by counteracting ACAP1–ARF6 inhibition
Wen, X., Mei, J., Jiang, Y., Qian, M., Wang, J., Xu, S., Xu, L., Xu, L., Liu, Q., Zhao, M., et al. (2026) · Nutrition and Diabetes · doi:10.1038/s41387-026-00452-8
Yang, W., Ouyang, G., Zhou, W., Lu, B., & Pang, Z. (2026) · Pharmaceuticals · doi:10.3390/ph19071107
“…regulate downstream metabolic and β -cell-related pathways partly through incretin signalling; SGLT2 inhibitors primarily reduce renal glucose reabsorption but are also associated with modulation of inflammation, oxidative stress, AGE-RAGE-related injury and mTOR/AMPK-related processes [9–21].”
Liu, T., Tang, Z., Aierken, Z., Zhang, J., & Lei, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1805548
“Membrane proteins are involved in cellular signal transduction (43), substance transport (44, 45), cell adhesion (46, 47), and other processes, playing a crucial role in modulating insulin signaling pathways and maintaining metabolic homeostasis (48 – 50).”
Signal Transduction and Drugs that Target Signaling Pathways
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_18
Statins and insulin resistance
Djabir, Y. Y., & Arsyad, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30263-3.00001-4
Vitamins, analog and effects on insulin signaling in the brain
Cardinali, C. A. E. F., Martins, Y. A., & Torrão, A. D. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30263-3.00028-2
Wang, J., Zhu, J., Zhu, C., Zan, X., Zhou, H., Zhi, Y., Liu, S., Liu, J., Zhu, M., Wang, J., et al. (2026) · Food & Function · doi:10.1039/d6fo02284g
Farahani, L. Z., Rouhani, S., Niyyati, M., Eslami, N., Harandi, M. F., & Mirjalali, H. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108759
Beyond bacterial dysbiosis: the emerging role of gut bacteriophages in type 2 diabetes
Tao, Y., Wang, Z., & Zhong, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1735631
“Chronic inflammation, impaired insulin signaling, and gut barrier dysfunction are key features of T2DM (Saltiel, 2021; Liang et al., 2023).”
Ruting, W., Hongxi, W., Liang, J., Huiping, L., Zhenjin, H., Zhang, R., Zhang, R., Hongzhen, T., & Jiang, F. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120705
Guo, Y., Jiao, J., & Zheng, X. (2026) · Diabetic Medicine · doi:10.1111/dme.70451
Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review
Shahid, S., Qamar, S., Qamar, F., Fatima, A., Máthé, E., & Khaliq, M. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/9614195
Role of Protein Kinase C in Insulin Resistance and Metabolic Syndrome
Cruz-Villarreal, D. E., Hernández-González, K. D., & Olivares-Reyes, J. A. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030025
“This signaling cascade is critical for regulating cellular proliferation, division, migration, and apoptosis [29,34].”
Mthethwa, L., & Khathi, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198674
Scalise, R., Zaccaria, B., SYED, R., Poornachandra, Y., FOTI, D. P., Mirabelli, M., & Brunetti, A. (2026) · Endocrines · doi:10.3390/endocrines7040059
Jia, Z., Wu, K., Qi, J., Huang, N., Liu, Y., 高秀梅, & Sun, R. (2026) · Phytotherapy Research · doi:10.1002/ptr.70442
Liu, H., Liang, Z., Tan, J., & Yuan, C. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1885995
“…threshold: 1000 kJ/(mol·nm)), followed sequentially by a 50-ps constant-volume (NVT) heating (0–298.15 K ) and a 50-ps constant-temperature constant-pressure (NPT) equilibration (1 bar, 298.15 K), with positional restraints of 1000 kJ/(mol·nm (Saltiel, 2021)) applied to protein heavy atoms.”
InfluentialAi, K., Wei, M., Zhang, N., Chen, S., Hong, H., Gong, Y., Huang, X., & Li, S. (2026) · Marine Life Science & Technology · doi:10.1007/s42995-026-00420-2
Biletska, O. M., Garyachiy, Y. V., & Shevchenko, A. S. (2026) · Experimental and Clinical Medicine · doi:10.35339/ekm.2026.95.2.bgs
Perspectives on tissue-selective insulin derivatives
Hejl, M., & Jiráček, J. (2026) · Open Biology · doi:10.1098/rsob.260175
Conti, P., Mastrangelo, F., Coppola, A., Barassi, G., Tetè, G., & Pandolfi, F. (2026) · Gastrointestinal Disorders · doi:10.3390/gidisord8040069
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.